Symptoms of the "Big Squeeze" can be seen in budget cuts, restricted and/or misallocated sales resources, incorrect financial accruals, investment uncertainty, and increased risk of inaccurate forecasting. Just a few of the end results are the year-over-year continued downward pressure on net sales, the turnover of brand and market access teams, the cutting of SG&A expenses, the inability to invest and innovate, and the burdening of future launches with unrealistic sales expectations.

• Review a data driven perspective of current macroeconomic trends in healthcare
• Examine the impact of growing payer control/patient cost sharing on brand performance
• Discuss how the complexity of the patient experience is changing the need for support
• Provide an overview of policy considerations that every manufacturer should have on their radar

KEY SPEAKER

Luke Greenwalt
VP, Market Access Center of Excellence, IQVIA